{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:11Z","timestamp":1786982711026,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s15010-021-01670-1","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:15:31Z","timestamp":1627085731000},"page":"833-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["COVID-19 and mucormycosis superinfection: the perfect storm"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-2235","authenticated-orcid":false,"given":"Jaffar A.","family":"Al-Tawfiq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Alhumaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer N.","family":"Alshukairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Hani","family":"Temsah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Al Mutair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Rabaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awadh","family":"Al-Omari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra","family":"Tirupathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaf","family":"AlQahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"AlBahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Dhama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,24]]},"reference":[{"key":"1670_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet"},{"key":"1670_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"6736","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;6736:1\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"key":"1670_CR3","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.11.2000230","author":"E Nicastri","year":"2020","unstructured":"Nicastri E, D\u2019Abramo A, Faggioni G, De Santis R, Mariano A, Lepore L, et al. Coronavirus disease (COVID-19) in a paucisymptomatic patient: Epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020. Eurosurveillance. 2020. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.11.2000230.","journal-title":"Eurosurveillance"},{"key":"1670_CR4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jiph.2020.09.003","volume":"13","author":"A Al-Omari","year":"2020","unstructured":"Al-Omari A, Alhuqbani WN, Zaidi ARZ, Al-Subaie MF, AlHindi AM, Abogosh AK, et al. Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: a descriptive cross-sectional study. J Infect Public Health. 2020;13:1639\u201344. https:\/\/doi.org\/10.1016\/j.jiph.2020.09.003.","journal-title":"J Infect Public Health"},{"key":"1670_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40001-020-00462-x","volume":"25","author":"A Al Mutair","year":"2020","unstructured":"Al Mutair A, Alhumaid S, Alhuqbani WN, Zaidi ARZ, Alkoraisi S, Al-Subaie MF, et al. Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study. Eur J Med Res. 2020;25:61. https:\/\/doi.org\/10.1186\/s40001-020-00462-x.","journal-title":"Eur J Med Res"},{"key":"1670_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jiph.2020.11.002","volume":"14","author":"JM AlJishi","year":"2021","unstructured":"AlJishi JM, Alhajjaj AH, Alkhabbaz FL, AlAbduljabar TH, Alsaif A, Alsaif H, et al. Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia. J Infect Public Health. 2021;14:6\u201311. https:\/\/doi.org\/10.1016\/j.jiph.2020.11.002.","journal-title":"J Infect Public Health"},{"key":"1670_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00028-20","volume":"33","author":"K Dhama","year":"2020","unstructured":"Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019\u2013COVID-19. Clin Microbiol Rev. 2020;33:1\u201348. https:\/\/doi.org\/10.1128\/CMR.00028-20.","journal-title":"Clin Microbiol Rev"},{"key":"1670_CR8","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.tmaid.2020.101904","volume":"38","author":"R Tirupathi","year":"2020","unstructured":"Tirupathi R, Muradova V, Shekhar R, Salim SA, Al-Tawfiq JA, Palabindala V. COVID-19 disparity among racial and ethnic minorities in the US: a cross sectional analysis. Travel Med Infect Dis. 2020;38:101904. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101904.","journal-title":"Travel Med Infect Dis"},{"key":"1670_CR9","doi-asserted-by":"publisher","first-page":"101711","DOI":"10.1016\/j.tmaid.2020.101711","volume":"35","author":"JA Al-Tawfiq","year":"2020","unstructured":"Al-Tawfiq JA, Leonardi R, Fasoli G, Rigamonti D. Prevalence and fatality rates of COVID-19: what are the reasons for the wide variations worldwide? Travel Med Infect Dis. 2020;35:101711. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101711.","journal-title":"Travel Med Infect Dis"},{"key":"1670_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27:992-1000.e3. https:\/\/doi.org\/10.1016\/j.chom.2020.04.009.","journal-title":"Cell Host Microbe"},{"key":"1670_CR11","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","volume":"2","author":"G Guaraldi","year":"2020","unstructured":"Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020;2:e474\u201384. https:\/\/doi.org\/10.1016\/S2665-9913(20)30173-9.","journal-title":"Lancet Rheumatol"},{"key":"1670_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, et al. COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment. J Fungi. 2020;6:1\u201317. https:\/\/doi.org\/10.3390\/jof6020091.","journal-title":"J Fungi"},{"key":"1670_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238825","author":"T Lahmer","year":"2021","unstructured":"Lahmer T, Kriescher S, Herner A, Rothe K, Spinner CD, Schneider J, et al. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0238825.","journal-title":"PLoS ONE"},{"key":"1670_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","volume":"185","author":"G Song","year":"2020","unstructured":"Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185:599\u2013606. https:\/\/doi.org\/10.1007\/s11046-020-00462-9.","journal-title":"Mycopathologia"},{"key":"1670_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","author":"JP Gangneux","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020. https:\/\/doi.org\/10.1016\/j.mycmed.2020.100971.","journal-title":"J Mycol Med"},{"key":"1670_CR16","unstructured":"BBC. Black fungus: India reports nearly 9,000 cases of rare infection\u2014BBC News 2021. 2021. https:\/\/www.bbc.com\/news\/world-asia-india-57217246. Accessed 28 May 2021."},{"key":"1670_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","author":"AK Singh","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr Clin Res Rev. 2021. https:\/\/doi.org\/10.1016\/j.dsx.2021.05.019.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"1670_CR18","unstructured":"Biswas S. Mucormycosis: The \u201cblack fungus\u201d maiming Covid patients in India\u2014BBC News 2021. 2021. https:\/\/www.bbc.com\/news\/world-asia-india-57027829. Accessed 29 May 2021."},{"key":"1670_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","volume":"25","author":"W Jeong","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25:26\u201334. https:\/\/doi.org\/10.1016\/j.cmi.2018.07.011.","journal-title":"Clin Microbiol Infect"},{"key":"1670_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jof4020046","author":"J Chander","year":"2018","unstructured":"Chander J, Kaur M, Singla N, Punia RPS, Singhal SK, Attri AK, et al. Mucormycosis: battle with the deadly enemy over a five-year period in India. J Fungi. 2018. https:\/\/doi.org\/10.3390\/jof4020046.","journal-title":"J Fungi"},{"key":"1670_CR21","unstructured":"A. Chakrabarti, P. Sood DWD. Estimating fungal infection burden in India using computational models: mucormycosis burden as a case study. ESCMID. 2021."},{"key":"1670_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms9030523","volume":"9","author":"H Prakash","year":"2021","unstructured":"Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021;9:1\u201312. https:\/\/doi.org\/10.3390\/microorganisms9030523.","journal-title":"Microorganisms"},{"key":"1670_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/mmy\/myy060","volume":"57","author":"H Prakash","year":"2019","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, Singh P, Xess I, Savio J, et al. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019;57:395\u2013402. https:\/\/doi.org\/10.1093\/mmy\/myy060.","journal-title":"Med Mycol"},{"key":"1670_CR24","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","volume":"69","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Gokhale T, Choudhury S, Deb A. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69:1002\u20134. https:\/\/doi.org\/10.4103\/ijo.IJO_3763_20.","journal-title":"Indian J Ophthalmol"},{"key":"1670_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","volume":"69","author":"M Sen","year":"2021","unstructured":"Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021;69:244\u201352. https:\/\/doi.org\/10.4103\/ijo.IJO_3774_20.","journal-title":"Indian J Ophthalmol"},{"key":"1670_CR26","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215121000992","author":"S Sharma","year":"2021","unstructured":"Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 2021. https:\/\/doi.org\/10.1017\/S0022215121000992.","journal-title":"J Laryngol Otol"},{"key":"1670_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/myc.13187","volume":"63","author":"Z Chegini","year":"2020","unstructured":"Chegini Z, Didehdar M, Khoshbayan A, Rajaeih S, Salehi M, Shariati A. Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: a systematic review of case reports and case series. Mycoses. 2020;63:1264\u201382. https:\/\/doi.org\/10.1111\/myc.13187.","journal-title":"Mycoses"},{"key":"1670_CR28","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.15190\/d.2021.5","volume":"9","author":"K Bhatt","year":"2021","unstructured":"Bhatt K, Agolli A, Patel MH, Garimella R, Devi M, Garcia E, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries. 2021;9:e126. https:\/\/doi.org\/10.15190\/d.2021.5.","journal-title":"Discoveries"},{"key":"1670_CR29","doi-asserted-by":"publisher","first-page":"n1238","DOI":"10.1136\/bmj.n1238","volume":"373","author":"O Dyer","year":"2021","unstructured":"Dyer O. COVID-19: India sees record deaths as \u201cblack fungus\u201d spreads fear. BMJ. 2021;373:n1238. https:\/\/doi.org\/10.1136\/bmj.n1238.","journal-title":"BMJ"},{"key":"1670_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01532-1","author":"A Moorthy","year":"2021","unstructured":"Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, et al. SARS-CoV-2, uncontrolled diabetes and corticosteroids\u2014an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021. https:\/\/doi.org\/10.1007\/s12663-021-01532-1.","journal-title":"J Maxillofac Oral Surg"},{"key":"1670_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","volume":"186","author":"D Garg","year":"2021","unstructured":"Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 2021;186:289\u201398. https:\/\/doi.org\/10.1007\/s11046-021-00528-2.","journal-title":"Mycopathologia"},{"key":"1670_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2021.105957","author":"A Maini","year":"2021","unstructured":"Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V. Sino-orbital mucormycosis in a COVID-19 patient: a case report. Int J Surg Case Rep. 2021. https:\/\/doi.org\/10.1016\/j.ijscr.2021.105957.","journal-title":"Int J Surg Case Rep"},{"key":"1670_CR33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10726","author":"S Mehta","year":"2020","unstructured":"Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020. https:\/\/doi.org\/10.7759\/cureus.10726.","journal-title":"Cureus"},{"key":"1670_CR34","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.4103\/ijo.IJO_1053_21","volume":"69","author":"R Rao","year":"2021","unstructured":"Rao R, Shetty AP, Nagesh CP. Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: clinico-radiological features. Indian J Ophthalmol. 2021;69:1627\u201330. https:\/\/doi.org\/10.4103\/ijo.IJO_1053_21.","journal-title":"Indian J Ophthalmol"},{"key":"1670_CR35","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.4103\/ijo.IJO_310_21","volume":"69","author":"SA Ravani","year":"2021","unstructured":"Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: Mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021;69:1563\u20138. https:\/\/doi.org\/10.4103\/ijo.IJO_310_21.","journal-title":"Indian J Ophthalmol"},{"key":"1670_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241663","author":"SM Revannavar","year":"2021","unstructured":"Revannavar SM, Supriya P, Samaga L, Vineeth K. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? BMJ Case Rep. 2021. https:\/\/doi.org\/10.1136\/bcr-2021-241663.","journal-title":"BMJ Case Rep"},{"key":"1670_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-021-02574-0","author":"M Saldanha","year":"2021","unstructured":"Saldanha M, Reddy R, Vincent MJ. Title of the article: paranasal mucormycosis in COVID-19 patient. Indian J Otolaryngol Head Neck Surg. 2021. https:\/\/doi.org\/10.1007\/s12070-021-02574-0.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"1670_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof6040265","volume":"6","author":"A Skiada","year":"2020","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi. 2020;6:1\u201320. https:\/\/doi.org\/10.3390\/jof6040265.","journal-title":"J Fungi"},{"key":"1670_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.riam.2019.09.001","volume":"37","author":"FJ Candel","year":"2020","unstructured":"Candel FJ, Pe\u00f1uelas M, Tabares C, Garcia-Vidal C, Matesanz M, Salavert M, et al. Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies. Rev Iberoam Micol. 2020;37:5\u201316. https:\/\/doi.org\/10.1016\/j.riam.2019.09.001.","journal-title":"Rev Iberoam Micol"},{"key":"1670_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.14740\/jmc3637","volume":"12","author":"K Alekseyev","year":"2021","unstructured":"Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral mucormycosis and COVID-19 pneumonia. J Med Cases. 2021;12:85\u20139. https:\/\/doi.org\/10.14740\/jmc3637.","journal-title":"J Med Cases"},{"key":"1670_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2021.01.010","author":"A-P Bellanger","year":"2021","unstructured":"Bellanger A-P, Navellou J-C, Lepiller Q, Brion A, Brunel A-S, Millon L, et al. Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient. Infect Dis Now. 2021. https:\/\/doi.org\/10.1016\/j.idnow.2021.01.010.","journal-title":"Infect Dis Now"},{"key":"1670_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2021.1903044","author":"LO Dallalzadeh","year":"2021","unstructured":"Dallalzadeh LO, Ozzello DJ, Liu CY, Kikkawa DO, Korn BS. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19. Orbit (London). 2021. https:\/\/doi.org\/10.1080\/01676830.2021.1903044.","journal-title":"Orbit (London)"},{"key":"1670_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mmcr.2021.03.006","volume":"32","author":"AK Johnson","year":"2021","unstructured":"Johnson AK, Ghazarian Z, Cendrowski KD, Persichino JG. Pulmonary aspergillosis and mucormycosis in a patient with COVID-19. Med Mycol Case Rep. 2021;32:64\u20137. https:\/\/doi.org\/10.1016\/j.mmcr.2021.03.006.","journal-title":"Med Mycol Case Rep"},{"key":"1670_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof7030174","volume":"7","author":"A Kanwar","year":"2021","unstructured":"Kanwar A, Jordan A, Olewiler S, Wehberg K, Cortes M, Jackson BR. A fatal case of rhizopus azygosporus pneumonia following covid-19. J Fungi. 2021;7:1\u20136. https:\/\/doi.org\/10.3390\/jof7030174.","journal-title":"J Fungi"},{"key":"1670_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22785","author":"M Karimi-Galougahi","year":"2021","unstructured":"Karimi-Galougahi M, Arastou S, Haseli S. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021. https:\/\/doi.org\/10.1002\/alr.22785.","journal-title":"Int Forum Allergy Rhinol"},{"key":"1670_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2021.101125","author":"A Khatri","year":"2021","unstructured":"Khatri A, Chang KM, Berlinrut I, Wallach F. Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient\u2014case report and review of literature. J Med Mycol. 2021. https:\/\/doi.org\/10.1016\/j.mycmed.2021.101125.","journal-title":"J Med Mycol"},{"key":"1670_CR47","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1097\/IOP.0000000000001889","volume":"37","author":"ZK Mekonnen","year":"2021","unstructured":"Mekonnen ZK, Ashraf DC, Jankowski T, Grob SR, Vagefi MR, Kersten RC, et al. Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthal Plast Reconstr Surg. 2021;37:E40\u20132. https:\/\/doi.org\/10.1097\/IOP.0000000000001889.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1670_CR48","doi-asserted-by":"publisher","first-page":"746","DOI":"10.5946\/CE.2020.180","volume":"53","author":"ES Do Monte","year":"2020","unstructured":"Do Monte ES, Dos Santos MEL, Ribeiro IB, De Oliveira LG, Baba ER, Hirsch BS, et al. Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: a case report. Clin Endosc. 2020;53:746\u20139. https:\/\/doi.org\/10.5946\/CE.2020.180.","journal-title":"Clin Endosc"},{"key":"1670_CR49","doi-asserted-by":"publisher","unstructured":"Pasero D, Sanna S, Liperi C, Piredda D, Pietro BG, Casadio L, et al. A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis. Infection. 2020. https:\/\/doi.org\/10.1007\/s15010-020-01561-x.","DOI":"10.1007\/s15010-020-01561-x"},{"key":"1670_CR50","doi-asserted-by":"publisher","unstructured":"Pauli MA, Pereira LM, Monteiro ML, de Camargo AR, Rabelo GD. Painful palatal lesion in a patient with COVID-19. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021. https:\/\/doi.org\/10.1016\/j.oooo.2021.03.010.","DOI":"10.1016\/j.oooo.2021.03.010"},{"key":"1670_CR51","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.radcr.2020.09.026","volume":"15","author":"DA Placik","year":"2020","unstructured":"Placik DA, Taylor WL, Wnuk NM. Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia. Radiol Case Rep. 2020;15:2378\u201381. https:\/\/doi.org\/10.1016\/j.radcr.2020.09.026.","journal-title":"Radiol Case Rep"},{"key":"1670_CR52","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211009450","author":"A Veisi","year":"2021","unstructured":"Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021. https:\/\/doi.org\/10.1177\/11206721211009450.","journal-title":"Eur J Ophthalmol"},{"key":"1670_CR53","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13163","author":"S Waizel-Haiat","year":"2021","unstructured":"Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon S, Romero-Gutierrez L. A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.13163.","journal-title":"Cureus"},{"key":"1670_CR54","doi-asserted-by":"publisher","first-page":"264.e5","DOI":"10.1016\/j.ajem.2020.09.032","volume":"42","author":"A Werthman-Ehrenreich","year":"2021","unstructured":"Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021;42:264.e5-264.e8. https:\/\/doi.org\/10.1016\/j.ajem.2020.09.032.","journal-title":"Am J Emerg Med"},{"key":"1670_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof7020088","volume":"7","author":"C Zurl","year":"2021","unstructured":"Zurl C, Hoenigl M, Schulz E, Hatzl S, Gorkiewicz G, Krause R, et al. Autopsy proven pulmonary mucormycosis due to Rhizopus microsporus in a critically Ill COVID-19 patient with underlying hematological malignancy. J Fungi. 2021;7:1\u20134. https:\/\/doi.org\/10.3390\/jof7020088.","journal-title":"J Fungi"},{"key":"1670_CR56","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/S2666-5247(20)30115-4","volume":"1","author":"B Hanley","year":"2020","unstructured":"Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1:e245\u201353. https:\/\/doi.org\/10.1016\/S2666-5247(20)30115-4.","journal-title":"Lancet Microbe"},{"key":"1670_CR57","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"OA Cornely","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19:e405\u201321. https:\/\/doi.org\/10.1016\/S1473-3099(19)30312-3.","journal-title":"Lancet Infect Dis"},{"key":"1670_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.04.008","author":"M Al-Obaidi","year":"2021","unstructured":"Al-Obaidi M, Youssefi B, Bardwell J, Bouzigard R, Le CH, Zangeneh TT. A comparative analysis of mucormycosis in immunosuppressed hosts including patients with uncontrolled diabetes in the Southwest United States. Am J Med. 2021. https:\/\/doi.org\/10.1016\/j.amjmed.2021.04.008.","journal-title":"Am J Med"},{"key":"1670_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nmni.2014.12.002","volume":"6","author":"F Bellazreg","year":"2015","unstructured":"Bellazreg F, Hattab Z, Meksi S, Mansouri S, Hachfi W, Kaabia N, et al. Outcome of mucormycosis after treatment: report of five cases. New Microbes New Infect. 2015;6:49\u201352. https:\/\/doi.org\/10.1016\/j.nmni.2014.12.002.","journal-title":"New Microbes New Infect"},{"key":"1670_CR60","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/562610","author":"CR Camara-Lemarroy","year":"2014","unstructured":"Camara-Lemarroy CR, Gonz\u00e1lez-Moreno EI, Rodr\u00edguez-Guti\u00e9rrez R, Rend\u00f3n-Ram\u00edrez EJ, Ayala-Cort\u00e9s AS, Fraga-Hern\u00e1ndez ML, et al. Clinical features and outcome of mucormycosis. Interdiscip Perspect Infect Dis. 2014. https:\/\/doi.org\/10.1155\/2014\/562610.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"1670_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.05.015","author":"L Szarpak","year":"2021","unstructured":"Szarpak L. Mucormycosis - a serious threat in the COVID-19 pandemic? J Infect. 2021. https:\/\/doi.org\/10.1016\/j.jinf.2021.05.015.","journal-title":"J Infect"},{"key":"1670_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/jof5030069","volume":"5","author":"KP Hartnett","year":"2019","unstructured":"Hartnett KP, Jackson BR, Perkins KM, Glowicz J, Kerins JL, Black SR, et al. A guide to investigating suspected outbreaks of mucormycosis in healthcare. J Fungi. 2019;5:69. https:\/\/doi.org\/10.3390\/jof5030069.","journal-title":"J Fungi"},{"key":"1670_CR63","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/BF03017426","volume":"49","author":"K Alsuwaida","year":"2002","unstructured":"Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anesth. 2002;49:880\u20132. https:\/\/doi.org\/10.1007\/BF03017426.","journal-title":"Can J Anesth"},{"key":"1670_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","author":"TM John","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe covid-19 converge: the perfect storm for mucormycosis. J Fungi. 2021. https:\/\/doi.org\/10.3390\/jof7040298.","journal-title":"J Fungi"},{"key":"1670_CR65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12663-021-01547-8","volume":"20","author":"DK Verma","year":"2021","unstructured":"Verma DK, Bali RK. COVID-19 and mucormycosis of the craniofacial skeleton: causal, contributory or coincidental? J Maxillofac Oral Surg. 2021;20:165\u20136. https:\/\/doi.org\/10.1007\/s12663-021-01547-8.","journal-title":"J Maxillofac Oral Surg"},{"key":"1670_CR66","doi-asserted-by":"publisher","DOI":"10.1177\/00368504211000906","author":"M Giri","year":"2021","unstructured":"Giri M, Puri A, Wang T, Guo S. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: a systemic review and meta-analysis. Sci Prog. 2021. https:\/\/doi.org\/10.1177\/00368504211000906.","journal-title":"Sci Prog"},{"key":"1670_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05915-0","author":"T Yin","year":"2021","unstructured":"Yin T, Li Y, Ying Y, Luo Z. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. BMC Infect Dis. 2021. https:\/\/doi.org\/10.1186\/s12879-021-05915-0.","journal-title":"BMC Infect Dis"},{"key":"1670_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250602","author":"X Li","year":"2021","unstructured":"Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0250602.","journal-title":"PLoS ONE"},{"key":"1670_CR69","doi-asserted-by":"publisher","first-page":"e24971","DOI":"10.1097\/MD.0000000000024971","volume":"100","author":"S Cheng","year":"2021","unstructured":"Cheng S, Zhao Y, Wang F, Chen Y, Kaminga AC, Xu H. Comorbidities\u2019 potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100:e24971. https:\/\/doi.org\/10.1097\/MD.0000000000024971.","journal-title":"Medicine (Baltimore)"},{"key":"1670_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108393","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China. Clin Immunol. 2020. https:\/\/doi.org\/10.1016\/j.clim.2020.108393.","journal-title":"Clin Immunol"},{"key":"1670_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ofid\/ofaa105","volume":"2020","author":"EK McCreary","year":"2019","unstructured":"McCreary EK, Coronavirus PJM, Disease, . Treatment: a review of early and emerging options. Open Forum Infect Dis. 2019;2020:7. https:\/\/doi.org\/10.1093\/ofid\/ofaa105.","journal-title":"Open Forum Infect Dis"},{"key":"1670_CR72","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(20)30317-2.","journal-title":"Lancet"},{"key":"1670_CR73","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2021436","author":"RECOVERY Collaborative Group","year":"2020","unstructured":"RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19\u2014preliminary report. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/nejmoa2021436.","journal-title":"N Engl J Med"},{"key":"1670_CR74","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.210521.001","author":"S AlBahrani","year":"2021","unstructured":"AlBahrani S, Al-Tawfiq JA, Jebakumar AZ, Alghamdi M, Zakary N, Seria M, et al. Clinical features and outcome of low and high corticosteroids in admitted COVID-19 patients. J Epidemiol Glob Health. 2021. https:\/\/doi.org\/10.2991\/jegh.k.210521.001.","journal-title":"J Epidemiol Glob Health"},{"key":"1670_CR75","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211027065","author":"AJ Rodriguez-Morales","year":"2021","unstructured":"Rodriguez-Morales AJ, Sah R, Millan-O\u00f1ate J, Gonzalez A, Montenegro-Idrogo JJ, Scherger S, et al. COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs. Ther Adv Infect Dis. 2021. https:\/\/doi.org\/10.1177\/20499361211027065.","journal-title":"Ther Adv Infect Dis"},{"key":"1670_CR76","doi-asserted-by":"publisher","first-page":"102169","DOI":"10.1016\/j.dsx.2021.06.006","volume":"15","author":"B Mulakavalupil","year":"2021","unstructured":"Mulakavalupil B, Vaity C, Joshi S, Misra A, Pandit RA. Absence of Case of Mucormycosis (March 2020\u2013May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit. Diabetes Metab Syndr Clin Res Rev. 2021;15:102169. https:\/\/doi.org\/10.1016\/j.dsx.2021.06.006.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"1670_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30847-1","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1.","journal-title":"Lancet Infect Dis"},{"key":"1670_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13334","author":"F Pakdel","year":"2021","unstructured":"Pakdel F, Ahmadikia K, Salehi M, Tabari A, Jafari R, Mehrparvar G, et al. Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicenter study from Iran. Mycoses. 2021. https:\/\/doi.org\/10.1111\/myc.13334.","journal-title":"Mycoses"},{"key":"1670_CR79","doi-asserted-by":"publisher","first-page":"e244096","DOI":"10.1136\/bcr-2021-244096","volume":"14","author":"RP Singh","year":"2021","unstructured":"Singh RP, Gupta N, Kaur T, Gupta A. Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19. BMJ Case Rep. 2021;14:e244096. https:\/\/doi.org\/10.1136\/bcr-2021-244096.","journal-title":"BMJ Case Rep"},{"key":"1670_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab176","author":"R Arjun","year":"2021","unstructured":"Arjun R, Felix V, Niyas VKM, Kumar MAS, Krishnan RB, Mohan V, et al. COVID-19 associated rhino-orbital mucormycosis: a single centre experience of ten cases. QJM An Int J Med. 2021. https:\/\/doi.org\/10.1093\/qjmed\/hcab176.","journal-title":"QJM An Int J Med"},{"key":"1670_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-021-02638-1","author":"PK Saidha","year":"2021","unstructured":"Saidha PK, Kapoor S, Das P, Gupta A, Kakkar V, Kumar A, et al. Mucormycosis of paranasal sinuses of odontogenic origin post COVID19 infection: a case series. Indian J Otolaryngol Head Neck Surg. 2021. https:\/\/doi.org\/10.1007\/s12070-021-02638-1.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"1670_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s12262-021-03007-6","author":"M Jain","year":"2021","unstructured":"Jain M, Tyagi R, Tyagi R, Jain G. Post-COVID-19 gastrointestinal invasive mucormycosis. Indian J Surg. 2021. https:\/\/doi.org\/10.1007\/s12262-021-03007-6.","journal-title":"Indian J Surg"},{"key":"1670_CR83","doi-asserted-by":"publisher","first-page":"e244232","DOI":"10.1136\/bcr-2021-244232","volume":"14","author":"HC Baskar","year":"2021","unstructured":"Baskar HC, Chandran A, Reddy CS, Singh S. Rhino-orbital mucormycosis in a COVID-19 patient. BMJ Case Rep. 2021;14:e244232. https:\/\/doi.org\/10.1136\/bcr-2021-244232.","journal-title":"BMJ Case Rep"},{"key":"1670_CR84","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26205","author":"SH Patankar","year":"2021","unstructured":"Patankar SH, Joshi AR, Muthe MM, Athawale A, Achhapalia Y. CT and MRI findings of invasive mucormycosis in the setting of COVID-19: experience from a single center in India. Am J Roentgenol. 2021. https:\/\/doi.org\/10.2214\/AJR.21.26205.","journal-title":"Am J Roentgenol"},{"key":"1670_CR85","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","volume":"69","author":"M Sen","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69:1670\u201392. https:\/\/doi.org\/10.4103\/ijo.IJO_1565_21.","journal-title":"Indian J Ophthalmol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01670-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-021-01670-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-021-01670-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T05:27:57Z","timestamp":1632720477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-021-01670-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,24]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1670"],"URL":"https:\/\/doi.org\/10.1007\/s15010-021-01670-1","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,24]]},"assertion":[{"value":"3 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}